Institut du Cancer de Montpellier - Val d'Aurelle: all 142 studies
Page 2 of 2. Open to participants first (50), then studies with results posted, then the rest; newest registration first within each.
- Hypnosis for Patients Treated With Adjuvant Chemotherapy for Breast Cancer(HYPNOVAL)CompletedNCT03250130Not applicable
- Assessing the Changes in Markers of Calcium Vitamin Metabolism of for Breast Cancer Adjuvant (CALCIOBS)CompletedNCT03249389Not applicable
- Implementation and Evaluation of a Social Journey Accompanied in Breast Cancer Diagnosis (EPARS SEIN)TerminatedNCT02893527Not applicable
- Comparison of KRAS/BRAF Mutational Status With Conventional Techniques and Plasma Samples AnalysisCompletedNCT02784639Not applicable
- Study in Patients With Peritoneal Carcinomatosis From CEA Overexpressing Digestive CancerCompletedNCT02784028Not applicable
- Safety and Efficacity of NFL101 as Tobacco TherapyCompletedNCT02521701Phase 1
- A Trial Assessing Several Schedules of Oral S-1 in Combination With a Fixed Dose of Oxaliplatin and IrinotecanCompletedNCT02387138Phase 1
- Activity of Regorafenib in Combination With Chemotherapy in Patients With Advanced Biliary Tract CancerCompletedNCT02386397Phase 1/2
- Comparison of Tumor Glucose Metabolism Before and After Artificial NutritionCompletedNCT02382237Not applicable
- Effect of the Rehabilitation Effort at Home in Patients With Head and Neck Tumor Treated With Curative IntentCompletedNCT02135185Phase 2
- Patients With Brain Metastases From HER2-positive Breast CancerCompletedNCT02135159Phase 1
- Immediate Implant Breast ReconstructionTerminatedNCT02055937Not applicable
- First Line Treatment of Patients With Metastatic Pancreatic Adenocarcinoma.CompletedNCT01964287Phase 1/2
- Prognostic and Predictive Value of HE4 Biomarker in Metastatic Ovarian CancerCompletedNCT01768156Not applicable
- Sorafenib in Combination With Irinotecan in Metastatic Colorectal Cancer Patients With KRAS Mutated TumorsCompletedNCT01715441Phase 2
- A Trial Evaluating Concurrent Whole Brain Radiotherapy and Iniparib in Multiple Non Operable Brain MetastasesTerminatedNCT01551680Phase 1
- 2nd-line Treatment of Metastatic Colorectal CancerTerminatedNCT01532804Phase 2
- Effect of a Tailored Program of Physical Activity and Nutritional Counseling on Fatigue Reduction in Breast Cancer Patients Receiving an Adjuvant TreatmentCompletedNCT01495650Phase 3
- Study of Vitamin D Supplementation Tailored to Vitamin D Deficiency in Breast Cancer PatientsCompletedNCT01480869Phase 3
- Multicenter Phase 2 Trial: a Tailored Strategy for Locally Advanced Rectal CarcinomaCompletedNCT01333709Phase 2
- Trial Evaluating Combined Chemotherapy in Patients With Metastatic Pancreatic AdenocarcinomaCompletedNCT01204372Phase 2
- Randomised Study of Mucositis Prevention After Radiochemotherapy Treatment for Head and Neck CancerCompletedNCT01149642Not applicable
- Sorafenib With Irinotecan in Metastatic Colorectal Cancer (mCRC) and K-RAS MutationCompletedNCT00989469Phase 1/2
- Sphincter-preserving Surgery After Preoperative Treatment of Ultra-low Rectal CarcinomaCompletedNCT00979680Phase 3
- Letrozole or Tamoxifen Citrate in Treating Older Postmenopausal Women Undergoing Surgery for Breast CancerCompletedNCT00949598Phase 3
- Everolimus, Bicalutamide, and Leuprolide Acetate in Treating Patients Undergoing Radiation Therapy For High-Risk Locally Advanced Prostate CancerCompletedNCT00943956Phase 1
- Sorafenib With or Without Gemcitabine and Oxaliplatin in Treating Patients With Locally Advanced, Unresectable, or Metastatic Liver CancerCompletedNCT00941967Phase 2
- Cetuximab and Trastuzumab in Treating Patients With Metastatic Pancreatic Cancer That Progressed After Previous Treatment With GemcitabineCompletedNCT00923299Phase 1/2
- Breast-Conserving Surgery and Whole-Breast Radiation Therapy With or Without Additional Radiation Therapy to the Tumor in Treating Women With Ductal Carcinoma in Situ (BONBIS)Active, not recruitingNCT00907868Not applicable
- Evaluation of an Apoptotic Test for Predicting Late Toxicities After Radiotherapy in Breast and Prostate Cancer PatientsCompletedNCT00893035
- Epoetin Beta in Patients Undergoing Chemotherapy for Solid TumorsTerminatedNCT00875004Not applicable
- Breast-Conserving Surgery Techniques in Treating Women With Breast CancerCompletedNCT00870415Phase 2
- Biological Factors in Predicting Response to Treatment in Patients With Esophageal Cancer or Rectal CancerCompletedNCT00628368Not applicable
- Gemcitabine With Or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Bladder CancerCompletedNCT00627432Phase 2
- Fotemustine in Treating Patients With Metastatic MelanomaTerminatedNCT00560118Phase 2
- Arginine/Omega-3 Fatty Acids/Nucleotides Nutritional Supplement in Treating Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation TherapyCompletedNCT00559156Phase 2
- Radiation Therapy During Surgery in Treating Older Women With Stage I Breast CancerCompletedNCT00556777Not applicable
- Gemcitabine, Cisplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder CancerCompletedNCT00556621Phase 1/2
- Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal CancerCompletedNCT00556413Phase 2
- Capecitabine, Irinotecan, and Oxaliplatin in Treating Patients With Metastatic CancerStatus unknownNCT00544063Phase 1
- Concomitant and Sequential Radiohormonotherapy in Adjuvant Breast CancerCompletedNCT00208273Phase 2
- Intensified Chemotherapy in CRC After Resection of Liver MetastasesCompletedNCT00208260Phase 2/3
← Institut du Cancer de Montpellier - Val d'Aurelle overview and focus areas